Teriflunomide Tablet, Film Coated
Product Images NDC 82249-112

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Teriflunomide (NDC 82249-112). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Civica Script Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Teriflunamidestructure (Teriflunamidestructure)

Chemical structure of Teriflunomide, showing its molecular framework including a trifluoromethyl group, amide linkage, and nitrile group.*

FDA Label Image

Teriflunamidefigure1 (Teriflunamidefigure1)

A line graph showing the percentage of disability progression sustained over 12 weeks for patients on placebo, 7 mg teriflunomide, and 14 mg teriflunomide. The x-axis represents time in weeks up to 108, and the y-axis shows disability progression as a percentage up to 40%. The placebo group consistently shows higher progression rates, reaching 27.3%, while 7 mg and 14 mg teriflunomide groups have lower rates (21.7% and 20.2% respectively), with 14 mg teriflunomide statistically significant compared to placebo (p<0.05).*

FDA Label Image

Teriflunamidefigure2 (Teriflunamidefigure2)

A line graph showing disability progression sustained over 12 weeks as a percentage, comparing placebo, 7 mg Teriflunomide, and 14 mg Teriflunomide groups. The x-axis represents time in weeks (0 to 108), and the y-axis represents percentage progression (0 to 40%). The 14 mg Teriflunomide group shows lower disability progression compared to placebo and 7 mg groups, with a noted statistical significance (p<0.05) versus placebo.*

FDA Label Image

Teriflunamide7mgcontainerlabel (Teriflunamide7mgcontainerlabel)

Teriflunomide Tablets 7 mg film-coated tablet label showing prescription drug information. The label includes dose strength (7 mg), quantity (30 tablets), distributor Civica Script LLC, and manufacturer Annora Pharma Pvt. Ltd. Dosage instructions, warnings, storage conditions, barcode, and a QR code linking to more information are also visible. The label has an unvarnished area marked 40 x 30 mm.*

FDA Label Image

Teriflunamide14mgcontainerlabel (Teriflunamide14mgcontainerlabel)

Label for Teriflunomide Tablets 14 mg oral film-coated tablets by Civica Script LLC. The label states the NDC 82249-112-30 and includes directions that each tablet contains 14 mg of teriflunomide, with instructions to dispense the medication guide separately. The package contains 30 tablets. Storage and usage warnings along with manufacturing details by Annora Pharma Pvt. Ltd. in India are also included on the label.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.